Jump to content

Autism Vote By Medical Marihuana Review Panel, Friday, July 31 At 1:00 Pm

Recommended Posts

  • Replies 58
  • Created
  • Last Reply

Top Posters In This Topic

Top Posters In This Topic

Popular Posts

Next Friday, July 31 is a very important day for the Michigan Medical Marijuana community. The MMMA, along with physicians, lawyers, and families have worked tirelessly for more than a year to add aut

This is about a small group of small minded individuals who cling on to the past ignorance and are unwillingly to open their eyes to the scientific facts and personal testimony of autism patients. The

Pretty intense day. The team did a fantastic job. The families brought tears to the hardest viewers. The submission was very fine. Dwight and the other parents did a great job on behalf of their k

Posted Images

This is a important subject in my life, I'm glad that I made it back to the forum before the date had passed. I'm going to give it my all to try and attend this..



Link to post
Share on other sites

Multi-talented Michigan attorney Michael Komorn is calling on families of children with autism to attend a crucial vote of the Medical Marihuana Review Panel on July 31st.

The Panel is considering whether to recommend approval of a petition to add autism to the list of medical conditions that can qualify a patient for the use of medical marijuana in Michigan.

Under Michigan’s rigorous standards, a child must obtain two certifications from physicians that the patient may receive palliative care from the application of marijuana medicines.

Komorn is putting his money where his mouth is. For families that have autism and attend the hearing, Komorn is offering to pay the cost of gas and provide a meal.

Komorn first made this offer on The Planet Green Trees Radio Show, of which he is the Host. He is also the leader of the Michigan Medical Marijuana Association, the MMMA, and it is in the pages of their website that this latest notice appears.

A previous hearing on the subject ended in adjournment due to a poorly-packed petition, which seemed grossly edited by the Michigan Attorney General‘s office.

From the website:

Next Friday, July 31 is a very important day for the Michigan Medical Marijuana community. The MMMA, along with physicians, lawyers, and families have worked tirelessly for more than a year to add autism as a qualifying condition under the Act, and next Friday is the vote to add or deny autism into the law.

Please attend this vote, particularly if you treat your child with marijuana, to show solidarity with the parents of autistic children and family members that have led this drive. Komorn Law has pledged to compensate food and gas for all families with children that attend.

Just attending the panel meeting can make a huge difference, there are many people with a debilitating condition who cannot make it. If you know someone in Lansing, ask them to attend. Friday is the ideal day to show respectful support that will have a real, meaningful impact on the panel’s vote, and on the futures of these parents and children in need.

I am sure all of you can understand how important this vote is for the families who have children afflicted with autism. I personally would like to believe that with all the hoopla and attention towards legalization lately the patients and families of patients are not lost or overlooked. Medical cannabis is the real deal. For the last 6 years we have all shared together in the miracles of this plant. We have danced on this forum together making history in Michigan as we implement the 2008 voter initiative. The battle continues and the fight is scheduled for July 31. Your appearance will be a strong showing of unity of our medical cannabis community. It will help provide evidence that medical cannabis is real, and safe access for those afflicted with autistism must be the next step for the MMMA.



Edited by bobandtorey
Link to post
Share on other sites

will the first response form Eden please be published here?  If she responds to me I'll show it right here.


I want to know why she voted "NO", denying the autistic sector of our citizenry this  natural relief. I've seen immediate positive

lasting results with the very first dose of cannabis, simply vaporized by an autistic person. Anyone witnessing this for themselves while denying

the relief to others owes me an explanation. 

Link to post
Share on other sites
what truths can we assume the no voters are working with?


IQ and the unknown effects on brain development were cited. That was to be expected. 


What I didn't expect was to hear a comparison of the use of cannabis as a palliative therapy, to the use of opioids as a palliative treatment that has resulted in overdoses and death. 


This was quickly corrected by another panel member, citing no overdoses from cannabis as ever being documented. 


You'd think once being corrected in such a way that you'd let it go. Mrs Wells didn't think so. Instead she stated that if you look at toxicology reports in overdoses resulting in death that marijuana is often present. 


Big mistake. 


This was immediately corrected in terms of association not equating causation, followed by physiological and pharmacological facts that plainly contradict her point. I was so grateful to hear sound rebuttals to the opposition from David Brogren and Dr Crocker. I could barely contain myself in the back of the room. 


I wouldn't hold it against the "no" votes too much. It's possible they might not have had the opportunity to study preclinical research to the extent that many here have. One respectful conversation at a time and we might win them over yet. Until then, leave message on the LARA FB page and send off some emails. This fight isn't over yet!     

Edited by in vivo
Link to post
Share on other sites
  • 4 weeks later...


Letter: Medical pot offers hope for autistic children

12:09 a.m. EDT August 25, 2015


(Photo: Steve Perez / The Detroit News)

In the United States, and in Michigan, autism is growing. In fact, it is growing at such an alarming rate that it has just recently been identified as a significant public health issue, due to statistics provided by the Center for Disease Control’s Autism and Developmental Disabilities Monitoring Network, a nationwide federal program that tracks autism rates around the country.

Estimates show that autism rates have risen in every report since tracking began in 2002, from 1 in 150 in 2002 to 1 in 68 in 2010. There is not a cure, however, new studies show, autism can be treated.

Some 800 pages of research along with 75 peer review articles on cannabis as a viable option for the treatment of autism were recently gathered by Dr. Christian Bogner, a prominent pediatrician currently in practice with one of Metro Detroit’s largest health systems, and presented to LARA, the Michigan Department of Licensing and Regulatory Affairs.

This data is part of a new, thoroughly researched petition to add autism to the list of conditions, which can be treated with medical marijuana. On July 31 in Lansing, the Michigan Medical Marijuana Review Panel voted yes to recommending medical cannabis as a legal, permissible treatment for all autistic patients. This would include pediatric and juvenile patients under the age of 18 with approval from two physicians. That recommendation is currently being considered by David Zimmer, director of LARA, a Gov. Rick Snyder appointee. The fate of thousands of autistic children now rests in his hands.

It has been a long and difficult road. Initially, and despite what can only be described as overwhelming evidence, LARA, tasked with addressing petitions for new conditions, initially refused to hold a hearing or even consider the petition. As a result, attorneys Tim Knowlton and myself, the Michigan Medical Marijuana Association, and Cannabis Patients United, sued LARA in Ingham County Court. It was only after nearly a year of litigation and foot dragging that LARA ceded its position. Attorney General Bill Schuette’s office “defended” LARA’s position by delaying for months, only yielding after the petitioner filed her brief with the court, days before oral arguments. Meanwhile, parents are treating their autistic children, typically orally in tandem with olive oil or other edible sources.

Today, we are at a crossroads. A pivotal moment in history.

All too often the issues regarding medical marijuana are politicized. What is at issue here is the right and desire of parents to protect and treat their children, without fear of breaking the law. What would each of us do for our children if similarly afflicted? In particular when there is medicine available that has already proven effective in treating epilepsy and autism? Our families should have choices. Michigan’s parents and their children should have hope.

Michael Komorn, president,

Michigan Medical Marijuana Association



Link to post
Share on other sites

Join the conversation

You can post now and register later. If you have an account, sign in now to post with your account.

Reply to this topic...

×   Pasted as rich text.   Paste as plain text instead

  Only 75 emoji are allowed.

×   Your link has been automatically embedded.   Display as a link instead

×   Your previous content has been restored.   Clear editor

×   You cannot paste images directly. Upload or insert images from URL.

  • Similar Content

    • By Michael Komorn
      The autism petition has been approved by the Michigan Medical Marijuana Review Panel on 5-4-2018 and has been sent to the Director of LARA for a final decision to add the condition to the qualifying conditions for the Medical Marihuana Program. 
      In the mean time, physicians in other states use medical marijuana to treat autistic patients already.
    • By Michael Komorn
      After the MMMA was enacted by a vote of 63% of Michigan voters in 2008, the legislature has declined to add any new qualifying conditions to protect patients from arrest.
      Senator Rick Jones even attempted to remove Glaucoma from the MMMP's list of qualifying conditions. Patients , caregivers and other interested parties wrote in opposition to the bill.
      A handful of petitions have been submitted over the years. LARA (and the previous MDCH department) have used various reasons and tricks to deny these petitions. Only Post Traumatic Stress Disorder has been added as a qualifying condition to the Michigan Medical Marihuana Act. Autism and Parkinson's disorder petitions were approved by the Michigan medical marihuana review board (the board consists mostly of physicians). These petitions were denied by the LARA director. The petitions were not deficient in any way and should have been accepted by LARA. We resubmitted the Autism petition again, with 20 additional research studies.
      Now, with the help of numerous patients, researchers, Dwight Z. and Dr. Christian Bogner along with the Michigan Medical Marijuana Association and Michael Komorn, we have assembled a massive amount of peer-reviewed medical research and government data to show that these conditions should be approved to protect patients, caregivers and physicians from arrest for the medical use of marijuana to treat their conditions.
      This project took months of work. Reading, organizing, searching and collecting thousands of pages of research from all over the world. Including the most up to date medical studies, peer-reviewed patient surveys and the national reviews of all medical marijuana studies by the National Academies of Science. The oldest peer-reviewed medical research paper cited within these petitions was from the first volume of The Lancet in 1889. Birch EA. The use of Indian hemp in the treatment of chronic chloral and chronic opium poisoning. The Lancet. 1889;133:625.
      Cannabis, Indian Hemp, Marijuana, whatever you call it, physicians were using this non-toxic plant in 1889 to treat chronic opium poisoning and opium addiction. As opioid based prescriptions are addicting and killing approximately 142 Americans each day in 2017, medical marijuana is a non-lethal non-toxic way to avoid "America enduring a death toll equal to September 11th every three weeks."
      The qualifying condition petitions were based primarily on the following:
      Already approved qualifying conditions in other medical marijuana states. Historical and ancient medical books. Patient self-reports and surveys. US Government Department of Health and Human Services Patent on using marijuana to treat many diseases and injuries, including brain injury on humans. Institute of Medicine 1999 report on medical marijuana. This report was the basis for the MMMA, specifically cited within the Michigan law, MCL 333.26422 (b). National Academies of Science (formerly the Institute of Medicine) 2017 updated report on medical marijuana. Included research not only supports each qualifying condition petition, but also answers questions that the LARA directors, physicians and medical marijuana review panel board members had asked of past petitioners. Reports on dosages, safety profiles of marijuana, statistics from the CDC and Poison Control, and information from NIH, FDA and the DEA are presented in the petitions. This information was included in order to compare the safety, effects and side-effects of medical marijuana with FDA approved prescription medications.
      All of the patients, caregivers, researchers, the Michigan Medical Marijuana Association and it's president Michael Komorn fully agree that marijuana should be removed from the Controlled Substances Act. Marijuana should continue to be studied as a treatment for every human and animal disease. Marijuana also should be submitted to the FDA for approval as a medicine. We fully support all clinical trials related to using marijuana as a treatment for any condition, disease or injury. As all of the scientific peer-reviewed published clinical trials show, marijuana is an effective medicine.
      The http://www.nih.gov website was heavily utilized throughout this project for locating scientific peer-reviewed published research, reports and information.
      The petitions are grouped by similar conditions, symptoms or mechanisms of treatment. Included in this post are some choice quotes from a few studies in each group of petitions.
      Marijuana and Medicine Assessing the Science Base 1999 report from the Institute of Medicine

      Medical Cannabis in Arizona: Patient Characteristics, Perceptions, and Impressions of Medical Cannabis Legalization.
      Preliminary assessment of the efficacy, tolerability and safety of a cannabis-based medicine (Sativex) inthe treatment of pain caused by rheumatoid arthritis
      Transdermal cannabidiol reduces inflammation and pain-related behaviours in a rat model of arthritis


      Effects of smoked marijuana in experimentally induced asthma.
      Effects of cannabis on lung function: a population-based cohort study
      Newspaper ad from 1876 selling marijuana cigarettes for treating asthma.

      You may laugh at a marijuana cigarette as a real medical treatment, but marijuana is a verified bronchodilator similar in strength to albuterol, the standard asthma medication. The medical efficacy of this specific brand of Asthma cigarettes were specifically exempted within the Single Convention on Narcotic Drugs as created by the United Nations. This means these marijuana cigarettes were still able to be sold after each country banned marijuana.
      The Health Effects of Cannabis and Cannabinoids The Current State of Evidence and Recommendations for Research (2017)
      The Impact of Marijuana Use on Glucose, Insulin, and Insulin Resistance among US Adults
      Marijuana Use Patterns Among Patients with Inflammatory Bowel Disease
      Minnesota Medical Cannabis Program: Patient Experiences from the First Program Year by the MN Department of Health 2016.
      Cannabinoids and the Urinary Bladder
      Cannabinoids and gastrointestinal motility: Animal and human studies
      Medical cannabis – the Canadian perspective
      Impact of cannabis treatment on the quality of life, weight and clinical disease activity in inflammatory bowel disease patients: a pilot prospective study.

      Medical Marijuana and Organ Transplantation: Drug of Abuse, or Medical Necessity?

      LARA statistics show the majority of the 250,000+ patients in the MMMA are using cannabis to treat chronic pain. As we know that the medical use of marijuana can treat “severe and chronic pain” already, it can and should be used to treat regular generic pain that is not severe and chronic.
      The reports and information from the Minnesota Department of Health on its medical marijuana program are very detailed and informative about patients experiences with medical marijuana.
      Minnesota Medical Cannabis Program: Patient Experiences from the First Program Year by the MN Department of Health 2016.
      Other states already approve of medical marijuana for Parkinson's Disease.
      Including: Georgia, Vermont, Connecticut, Florida, Illinois, Massachusetts, New Hampshire, Ohio, New Mexico, New York, Pennsylvania, West Virginia and California

      Tourette’s Syndrome is an approved medical marijuana qualifying condition in Arkansas, Illinois, Minnesota and Ohio. While the MMMA covers persistant and severe Muscle Spasms, Tourette's Syndrome sufferers may not have the severe symptoms that qualify.
      The 1999 Institute of Medicine report states that marijuana can be used to treat Tourettes

      Pennsylvania Medical Marijuana Program lists Autism as a qualifying condition.
      There are two clinical trials for Autism and cannabis in 2017:
      Cannabinoids for Behavioral Problems in Autism Spectrum Disorder: A Double Blind, Randomized, Placebo-controlled Trial With Crossover.
      Cannabidivarin (CBDV) vs. Placebo in Children With Autism Spectrum Disorder (ASD)
      Safety and Efficacy of Medical Cannabis Oil for Behavioral and Psychological Symptoms of Dementia: An-Open Label, Add-On, Pilot Study.
      An Open Label Study of the Use of Dronabinol (Marinol) in the Management of Treatment-Resistant Self-Injurious Behavior in 10 Retarded Adolescent Patients
    • By Michael Komorn
      Effective Monday, February 26, 2018. the Bureau of Medical Marihuana Regulation will begin operating at its new location at2407 North Grand River, Lansing, Michigan.  Applications for a state operating license for a marihuana facility will no longer be accepted at 611 West Ottawa Street. Those applications and payments for application fees and regulatory assessments will be accepted at the new location between the hours of 8 a.m. and 5 p.m., Monday through Friday.  To allow time for processing, please arrive no later than 4:30 p.m.
      Applications for the medical marihuana program will not be accepted on-site.  Individuals should follow the instructions provided on the application for registry identification card and mail the completed form, required supporting documentation, and fee (if applicable) to the address provided on the form.
      LARA is an equal opportunity employer/program.  
      Auxiliary aids, services and other reasonable accommodations are available upon request to individuals with disabilities. 
      For more information about LARA, please visit www.michigan.gov/medicalmarihuana
      Follow us on Twitter www.twitter.com/michiganLARA
      “Like” us on Facebook or find us on YouTube www.youtube.com/michiganLARA
    • By ANFK88
      Hey guys! Sorry if this is in the wrong area but I’m a bit worried... LARA received my application and money order on Feb. 17, and it still hasn’t been cashed as of today (the 24th.) Is this unusual? Everything I’ve read says they want to cash it ASAP and usually do within 2-4 days of receiving. Anyone know what’s up? Thanks! 
    • By Michael Komorn
      Medical marijuana used to treat autism-related disorders

      PALM BEACH COUNTY, Fla. — Abigail Dar’s son, Yuval, is 24-years-old, and she says he is severely autistic.
      Mollie Ryckman Barrett’s youngest daughter, Sumer, is 13-years-old and has Asperger Syndrome. This is the story of two moms looking for answers to help their children.
      "Medication helps, at times. Sumer, who is doing well in seventh grade, takes two of them," Barrett said. “One helps her focus with her brain and one relaxes her brain a little bit.”
      Always, though, there is the nagging worry. “How safe really is the medication we are giving our children today?” asked Barrett.
      Dar gave her autistic son higher and higher doses of pharmaceutical prescription medications for years in a bid to control his anxiety and aggressiveness.
      Dar complained, “They just give medication hoping it will give an answer, which it doesn’t, and I get my kid crazier and crazier.”    
      Amid that frustration, Dar had an alternative within reach. 
      “Israel is much more liberal regarding medical cannabis,” Dar said.  
      Dar spoke from her home outside Tel Aviv, Israel, where she is at the forefront of medical marijuana research. “I gave him (Yuval) his first dose and it was a miracle,” she remembered.   
      The dose she talked about was a strain of medical cannabis she and her son’s psychiatrist settled on after trial and error. Yuval became calmer, less anxious, more attentive.
      “It’s a game changer,” Abigail said, “it gave us quality of life.”
      Barrett said she wants the same opportunity for her daughter, but their home in West Palm Beach, Florida is far removed from the access, and attitudes, available in Israel.
      “We should have a right to decide in our home what is in the best interest of our children, what is the safest alternative option for them,” Barrett said. 
      She said she hopes to someday use cannabis derived oils for Sumer, but her child’s doctor does not agree with the idea. “He just says,” Barrett recalled, “that he doesn’t feel it’s a safe option and she seems OK on her medicine and there really are no side effects.”
      The American Academy of Pediatrics does not support medical marijuana use for autism-related disorders. One big issue, experts say, is the fact that there are many strains of cannabinoids in marijuana.
      Dr. Norina Ocampo is a South Florida pediatrician. “The other issue is they think probably all these compounds work synergistically with each other to help, so how do you pick which one will be the right compound,” she said. 
      Dar is working with Israeli doctors, pushing for much more extensive research on that prime question. “Today we have over 300 kids having access to medical cannabis,” she said. 
      Medical marijuana used to treat autism-related disorders
      Michael Williams
      9:56 PM, Feb 5, 2018
      2:03 PM, Feb 6, 2018

  • Create New...